Page last updated: 2024-08-25

daunomycinone and carmustine

daunomycinone has been researched along with carmustine in 1 studies

*Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed) [MeSH]

*Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed) [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kennedy, KA; Sartorelli, AC; Siegfried, JM; Tritton, TR1

Other Studies

1 other study(ies) available for daunomycinone and carmustine

ArticleYear
Effects of anthracyclines on oxygenated and hypoxic tumor cells.
    Cancer research, 1983, Volume: 43, Issue:1

    Topics: Animals; Antibiotics, Antineoplastic; Carmustine; Cell Survival; Chromatography, High Pressure Liquid; Daunorubicin; Doxorubicin; Hypoxia; Mitomycin; Mitomycins; Naphthacenes; Sarcoma 180; Streptonigrin

1983